Form 4: Guardant Health Director Sells Shares

Guardant Health Director Tariq Musa sold 116 shares of common stock for $96.25 per share under a pre-arranged Rule 10b5-1 plan.

Summary

• Tariq Musa, a Director of Guardant Health, Inc. (GH), reported a sale of common stock.
• The transaction involved the disposition of 116 shares of common stock.
• The shares were sold at a price of $96.25 per share.
• The transaction occurred on November 19, 2025.
• Following this transaction, Tariq Musa directly beneficially owns 7,859 shares of Guardant Health common stock.
• The sale was conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.

Sentiment

Score: 5

Explanation: The sale of shares by a director, while technically insider selling, was conducted under a Rule 10b5-1 plan, which typically indicates a pre-arranged transaction not based on recent material non-public information. This mitigates the potential negative sentiment often associated with insider sales.

Positives

• The sale was executed under a Rule 10b5-1 plan, which suggests the transaction was pre-scheduled and not based on recent material non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence in the company's near-term prospects, although this is mitigated by the pre-arranged nature.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might view the director's sale of shares, even if pre-planned, with some scrutiny, potentially leading to minor negative sentiment regarding the stock.

Key Dates

Recommendation

A single insider sale, particularly one executed under a Rule 10b5-1 plan, is generally not a strong enough signal on its own to warrant a 'buy' or 'sell' recommendation. It represents a pre-scheduled personal financial decision rather than a reaction to new company-specific information. Investors should consider this transaction as a data point within a broader analysis of the company's fundamentals and market conditions.

Keywords

Guardant Health, GH, Insider Trading, Form 4, Stock Sale, Director, Tariq Musa, 10b5-1 Plan